Updated PHS guidelines recommend HIV, HBV, and HCV testing for pediatric transplant candidates under 12

The U.S. Public Health Service has issued updated guidelines for testing pediatric transplant candidates under 12 years of age for HIV, Hepatitis B virus (HBV), and Hepatitis C virus (HCV). The guidelines apply to this specific population within the United States. The publication is a guideline document; no specific study design, sample size, or follow-up duration is reported.

No intervention, comparator, primary outcome, or main results with exact numbers are provided in the input data. The guidelines focus on the recommendation for testing. Safety and tolerability information, including adverse events and discontinuations, are not reported.

Key limitations include the absence of reported supporting evidence, study details, or a practice relevance statement from the input. The funding sources and potential conflicts of interest are also not reported. The clinical relevance is based solely on the guideline recommendation itself, and clinicians should refer to the complete guideline for implementation specifics and any underlying evidence review.